SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-312289
Filing Date
2021-10-29
Accepted
2021-10-29 06:49:56
Documents
12
Period of Report
2021-10-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d251146d8k.htm   iXBRL 8-K 26224
  Complete submission text file 0001193125-21-312289.txt   149129

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA epzm-20211027.xsd EX-101.SCH 2890
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20211027_lab.xml EX-101.LAB 18140
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20211027_pre.xml EX-101.PRE 11407
5 EXTRACTED XBRL INSTANCE DOCUMENT d251146d8k_htm.xml XML 3342
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 211360562
SIC: 2834 Pharmaceutical Preparations